عرض بسيط للتسجيلة

المؤلفAbouGalala, Khalid
المؤلفElsayed, Basant
المؤلفElmarasi, Mohamed
المؤلفKotob, Mona
المؤلفTaha, Reham
المؤلفAbbasher, Fardous
المؤلفAmarah, Ahmed
المؤلفEl Hamawi, Mariam
المؤلفAlbayat, Soha S.
المؤلفAbdulmajeed, Jazeel
المؤلفSallam, Mohamed A.H.
المؤلفAl-Shamali, Maha H.M.
المؤلفAl-Romaihi, Hamad E.
المؤلفBansal, Devendra
المؤلفMusa, Omran A.H.
المؤلفFarag, Elmoubasher
المؤلفAl-Thani, Mohammed H.J.
المؤلفChivese, Tawanda
المؤلفEmara, Mohamed M.
تاريخ الإتاحة2023-05-03T09:45:09Z
تاريخ النشر2023-02-20
اسم المنشورMicrobiology Research
المعرّفhttp://dx.doi.org/10.3390/microbiolres14010023
الاقتباسAbouGalala, K., Elsayed, B., Elmarasi, M., Kotob, M., Taha, R., Abbasher, F., ... & Emara, M. M. (2023). Association between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study. Microbiology Research, 14(1), 289-296.
الرقم المعياري الدولي للكتاب2036-7473
معرّف المصادر الموحدhttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85150946478&origin=inward
معرّف المصادر الموحدhttp://hdl.handle.net/10576/42274
الملخصThis study assessed the association between multimorbidity and mortality from COVID-19 in the Middle East and North Africa region, where such data are scarce. We conducted a cross-sectional study using data of all cases with COVID-19 reported to the Ministry of Public Health of Qatar from March to September 2020. Data on pre-existing comorbidities were collected using a questionnaire and multimorbidity was defined as having at least two comorbidities. Proportions of deaths were compared by comorbidity and multimorbidity status and multivariable logistic regression analyses were carried out. A total of 92,426 participants with a mean age of 37.0 years (SD 11.0) were included. Mortality due to COVID-19 was associated with gastrointestinal diseases (aOR 3.1, 95% CI 1.16–8.30), respiratory diseases (aOR 2.9, 95% CI 1.57–5.26), neurological diseases (aOR 2.6, 95% CI 1.19–5.54), diabetes (aOR 1.8, 95% CI 1.24–2.61), and CVD (aOR 1.5, 95% CI 1.03–2.22). COVID-19 mortality was strongly associated with increasing multimorbidity; one comorbidity (aOR 2.0, 95% CI 1.28–3.12), two comorbidities (aOR 2.8, 95% CI 1.79–4.38), three comorbidities (aOR 6.0, 95% 3.34–10.86) and four or more comorbidities (aOR 4.15, 95% 1.3–12.88). This study demonstrates a strong association between COVID-19 mortality and multimorbidity in Qatar.
اللغةen
الناشرPagePress
الموضوعchronic diseases
comorbidities
COVID-19
Middle East and North Africa
mortality
multimorbidity
pre-existing diseases
SARS-CoV-2
العنوانAssociation between Multimorbidity and COVID-19 Mortality in Qatar: A Cross-Sectional Study
النوعArticle
الصفحات289-296
رقم العدد1
رقم المجلد14
ESSN2036-7481
dc.accessType Open Access


الملفات في هذه التسجيلة

Thumbnail

هذه التسجيلة تظهر في المجموعات التالية

عرض بسيط للتسجيلة